XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2023 $ 54,240 $ 306,187,314 $ 529,321 $ (283,289,661) $ 23,481,214
Beginning Balance (in shares) at Dec. 31, 2023 54,240,265        
Stock-based compensation   959,465     959,465
Issuance of common stock and warrants from rights offering, net of fees incurred $ 54 53,185     53,239
Issuance of common stock and warrants from rights offering, net of fees incurred (in shares) 53,290        
Other comprehensive loss, foreign currency translation adjustment, net of tax     1,223,175   1,223,175
Net Income (Loss)       (6,088,711) (6,088,711)
Ending Balance at Mar. 31, 2024 $ 54,294 307,199,964 1,752,496 (289,378,372) 19,628,382
Ending Balance (in shares) at Mar. 31, 2024 54,293,555        
Beginning Balance at Dec. 31, 2024 $ 54,830 310,808,711 4,252,013 (304,008,618) 11,106,936
Beginning Balance (in shares) at Dec. 31, 2024 54,830,146        
Stock-based compensation $ 32 818,394     818,426
Stock-based compensation (in shares) 32,321        
Issuance of common stock from exercise of warrants $ 1,417 1,438,411     1,439,828
Issuance of common stock from exercise of warrants (in shares) 1,417,208        
Issuance of common stock and warrants from rights offering, net of fees incurred $ 6,250 5,386,056     5,392,306
Issuance of common stock and warrants from rights offering, net of fees incurred (in shares) 6,249,791        
Other comprehensive loss, foreign currency translation adjustment, net of tax     (2,736,354)   (2,736,354)
Net Income (Loss) $ 0 0 0 (1,478,358) (1,478,358)
Ending Balance at Mar. 31, 2025 $ 62,529 $ 318,451,572 $ 1,515,659 $ (305,486,976) $ 14,542,784
Ending Balance (in shares) at Mar. 31, 2025 62,529,466